Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Project BioShield Should Exempt Device Firms From Liability – AdvaMed

This article was originally published in The Gray Sheet

Executive Summary

Liability protections under Project BioShield should be extended to companies that make countermeasure devices and diagnostics available in an emergency situation, AdvaMed says
Advertisement

Related Content

FDA Draft Guidance Proposes Emergency-Use Authorization Policies
FDA Draft Guidance Proposes Emergency-Use Authorization Policies
Project BioShield Mandatory Funding Meets Resistance In House
Lieberman/Hatch Bill Offers Incentives For Countermeasure Development
FDA Product Liability Safeguard Elevated During Consideration Of HEALTH Act
FDA Product Liability Safeguard Elevated During Consideration Of HEALTH Act
Advertisement
UsernamePublicRestriction

Register

MT018132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel